✦ LIBER ✦

Chemoimmunotherapy for multiple myeloma

✍ Scribed by Raymond Alexanian; Jordan Gutterman; Dennis Dixon; Sydney Salmon; John Bonnet; Arthur Haut

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 582 KB
Volume: 47
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810415)47:8<1923::aid-cncr2820470802>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy for multiple myeloma

✍ Raymond Alexanian; Robert Dreicer 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Combination therapy for multiple myeloma

✍ Dr. Raymond Alexanian; Sydney Salmon; John Bonnet; Edmund Gehan; Arthur Haut; Ja 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Combination chemotherapy for multiple my

Combination chemotherapy for multiple myeloma

✍ Raymond Alexanian; John Bonnet; Edmund Gehan; Arthur Haut; James Hewlett; Montag 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Nonsecretory multiple myeloma

✍ Daniel Rubio-Felix; Manuel Giralt; M. Pilar Giraldo; Jose M. Martinez-Peñuela; F 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Nonsecretory multiple myeloma

✍ Robert Dreicer; Raymond Alexanian 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 1 views

HyperCVAD for VAD-resistant multiple mye

HyperCVAD for VAD-resistant multiple myeloma

✍ Dimopoulos, Meletios A.; Weber, Donna; Kantarjian, Hagop; Delasalle, Kay B.; Ale 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 1 views

More effective and safer regimens are needed for patients who have advanced multiple myeloma resistant to or relapsing despite prior treatment with alkylating agents and VAD. We treated 58 such patients using the combination of twice daily cyclophosphamide (total dose 1.8 g/mz) and VAD (hyperCVAD).